Stay updated on Entinostat + Pembrolizumab in Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.

Latest updates to the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page
- Check4 days agoChange DetectedThe bottom of the page shows a revision stamp updated from v3.6.4 to v3.6.5, indicating a minor template or deployment update. This appears to be a routine system update rather than a change to study information.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now shows a new revision tag (v3.6.4) and additional date entries, replacing the prior revision tag (v3.6.3). This indicates a maintenance/update to the page rather than changes to the study data.SummaryDifference0.4%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe revision label on the page now shows v3.6.3, replacing the prior v3.6.2. This indicates a new revision of the study record.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now displays an updated revision label, 'Revision: v3.6.2', replacing the previous 'Revision: v3.6.0'. This indicates a routine platform version update without changes to study details or navigation.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now indicates the study is no longer looking for participants and adds several help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), along with a formatting adjustment to the Intervention/Treatment heading and an updated revision version.SummaryDifference0.4%

- Check69 days agoChange DetectedThe revision tag on the page was updated from v3.5.4 to v3.5.5. This represents a minor update to the ClinicalTrials.gov record without changes to core study information.SummaryDifference0.1%

Stay in the know with updates to Entinostat + Pembrolizumab in Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.